Long consolidation, some more time for a good breakoutEnter if it closes above 780 in weekly and daily chart
SL 675
Target: will update according to trend
SL will be activated only after entry condition is satisfied.
Note: Trade at your own risk.
19.50INR
1.66 BINR
27.16 BINR
34.20 M
About AARTI DRUGS LTD
Sector
CEO
Prakash Moreshwar Patil
Headquarters
Mumbai
Website
Employees (FY)
2.59 K
Founded
1984
ISIN
INE767A01016
FIGI
BBG000CMRNH9
Aarti Drugs Ltd. engages in the development, manufacture and market of pharmaceutical products. The firm operates through the Out of India, and India geographical segments. Its products include active pharmaceutical ingredient, specialty chemicals, pharma intermediate, products under development, and product under pipeline. The company was founded on September 28, 1984 and is headquartered in Mumbai, India.
AARTI DRUGS LTDAARTI DRUGS LTD my view is bullish .
I INVESTED IN CMP@485
First target@570
Second target@650
SL@422
Aarti Drugs - Momentum CallThis stock is looking for a break out from the Inverse Head and Shoulder Pattern on the weekly charts. Further, RSI is showing bullish Trend. Buy this stock at Current Market Price @ 538 with a stop loss of 490 and a Target of 700 for the Short Term
AARTIDRUGS- VCP in 45 min Bars > 40 FInalAARTIDRUGS- VCP in 45 min Bars > 40 FInal
1) VCP formation
2)Consolidation
3) Ready to breakot
Aarti Drugs - Fibonacci Retracement ToolWe have used fibonacci retracement tool to check the retracement of price. The price has reached 0.382 and once cross this, we can see change of trend. We can also see the EMA20 about to cross EMA200, which will show bullishness in the stock. The fibonacci at 0.5 level, 0.618 as resistances, and on
AARTIDRUGS - uptrend - educational purposeAARTIDRUGS - uptrend
Monthly breakout
Day handle confirmation received
Two target set for my knowledge purpose
Risk -8%
If it break 470 level, retest required.
Aartidrugs -300 apna + fundamental + balajiAartidrugs -300 apna + fundamental + balaji
1) Rounding bottom Pattern may form cup and handle further
2) CUP line following
3) Perfect entry
4) Comment your opinion
Aarti drugs- A pre breakout tradeAnother stock from pharma sector which hasn't rallied.
IHNS pattern breakout above 575.
Levels mentioned on chart. Good move can be seen post breakout.
Please follow me if you like my analysis:)
Big move waiting As per 4 hr, daily and weekly chart pattern of the stock, MACD and RSI is giving bullish signals, so limited down risk of 480, the stock is ready fo4 550 and 600 price zone.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AARTIDRUGS is 495.00 INR — it has increased by 0.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange AARTI DRUGS LTD stocks are traded under the ticker AARTIDRUGS.
AARTI DRUGS LTD is going to release the next earnings report on May 16, 2024. Keep track of upcoming events with our Earnings Calendar.
AARTIDRUGS stock is 2.79% volatile and has beta coefficient of 0.61. Check out the list of the most volatile stocks — is AARTI DRUGS LTD there?
One year price forecast for AARTI DRUGS LTD has a max estimate of 562.00 INR and a min estimate of 562.00 INR.
AARTIDRUGS earnings for the last quarter are 4.30 INR per share, whereas the estimation was 5.90 INR resulting in a −27.12% surprise. The estimated earnings for the next quarter are 4.40 INR per share. See more details about AARTI DRUGS LTD earnings.
AARTI DRUGS LTD revenue for the last quarter amounts to 6.42 B INR despite the estimated figure of 7.01 B INR. In the next quarter revenue is expected to reach 6.34 B INR.
Yes, you can track AARTI DRUGS LTD financials in yearly and quarterly reports right on TradingView.
AARTIDRUGS stock has fallen by 2.19% compared to the previous week, the month change is a 10.44% rise, over the last year AARTI DRUGS LTD has showed a 15.40% increase.
AARTIDRUGS net income for the last quarter is 366.71 M INR, while the quarter before that showed 395.86 M INR of net income which accounts for −7.36% change. Track more AARTI DRUGS LTD financial stats to get the full picture.
Today AARTI DRUGS LTD has the market capitalization of 45.35 B, it has increased by 4.34% over the last week.
AARTI DRUGS LTD dividend yield was 0.30% in 2022, and payout ratio reached 5.57%. The year before the numbers were 0.23% and 4.52% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, AARTIDRUGS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AARTI DRUGS LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 2.59 K employees. See our rating of the largest employees — is AARTI DRUGS LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AARTI DRUGS LTD technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AARTI DRUGS LTD stock shows the strong buy signal. See more of AARTI DRUGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on AARTI DRUGS LTD future price: according to them, AARTIDRUGS price has a max estimate of 562.00 INR and a min estimate of 562.00 INR. Read a more detailed AARTI DRUGS LTD forecast: see what analysts think of AARTI DRUGS LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AARTI DRUGS LTD EBITDA is 3.24 B INR, and current EBITDA margin is 11.60%. See more stats in AARTI DRUGS LTD financial statements.